Discover personalized clinical trial options designed to support your journey, safely, confidentially, and at no cost.
Takes less than 2 minutes • 100% confidential
Type 2 diabetes is a chronic metabolic disease in which the body either does not produce enough insu…
Increased thirst, Frequent urination, Unexplained fatigue and more.
Obesity and excess visceral adiposity; Physical inactivity and sedentary lifestyle.
Metformin, GLP-1 Receptor Agonists and more.
Symptoms
Common Symptoms
Quality of Life Impact
Uncontrolled diabetes leads to serious complications including heart disease, kidney failure, blindness, and lower-limb amputation. With good glucose management, people with type 2 diabetes can live full, healthy lives.
With the right care and support, most people live full, active lives.
Causes & Risk Factors
Health Insights
Active Global Trials
67+
Across all phases
Symptom Frequency
78%
Patients report primary symptom
Trial Improvement Rate
68%
Report improvement within 3 months
Avg. Trial Duration
14 mo
Median length of participation
Symptom Frequency Among Patients
Treatment
Cornerstone first-line medication, reduces hepatic glucose production, low cost, well tolerated.
Semaglutide, liraglutide, weight loss, cardiovascular protection, injectable or oral.
Empagliflozin, dapagliflozin, kidney and heart protection, excretes glucose in urine.
Required when oral medications cannot maintain target glucose levels.
Mediterranean or low-carb diet + 150 min/week exercise, can achieve remission.
For BMI ≥ 35, can produce complete diabetes remission in up to 80% of cases.
Clinical Trials
National Institute of Diabetes
Comparing a structured low-carbohydrate eating plan to standard dietary guidelines for blood sugar management.
NCT05634892
Eli Lilly UAE
Head-to-head comparison of tirzepatide and insulin glargine in UAE adults with poorly controlled T2D.
NCT05401245
Dexcom
Assessing whether continuous glucose monitoring improves outcomes and reduces hypoglycemia in elderly T2D patients.
NCT05198765
Daily Life
You are not alone. Millions of people navigate this condition every day, and with the right support system and treatments, a meaningful life is absolutely within reach.
Community Support
Connect with thousands of patients and caregivers
Digital Tools
Track symptoms and share insights with your care team
Specialist Network
Access to leading neurologists and researchers
Education Hub
Evidence-based resources tailored to your journey
Why Join a Trial
Try innovative therapies before they're widely available, some with breakthrough potential.
Receive close monitoring and support from leading specialists throughout the trial.
Study-related care, tests, and the investigational treatment are provided at no charge.
Research Pipeline
Current pipeline overview for Type 2 Diabetes
Pipeline data is indicative. Source: ClinicalTrials.gov & WHO ICTRP.
Patient Stories
“The coordinator called me in Arabic the next morning. I felt seen for the first time in my healthcare journey.”
Maria S.
✓ Enrolled in trial“The coordinator called me in Arabic the next morning. I felt seen for the first time in my healthcare journey.”
Maria S.
✓ Enrolled in trialPublished with patient consent. Details may be anonymised.
News
Tirzepatide Shows 22% Weight Loss in Landmark SURMOUNT-5 Trial
Eli Lilly's tirzepatide demonstrated superior weight loss compared to semaglutide in the head-to-head SURMOUNT-5 trial, with a mean reduction of 22.8% body weight.
NIH · Mar 10, 2025
FDA Issues Safety Alert on Two Popular SGLT-2 Inhibitors Over Rare Kidney Risk
The FDA has updated safety labeling for empagliflozin and dapagliflozin following reports of acute kidney injury in patients with pre-existing renal impairment.
FDA · Mar 8, 2025
UAE Reports 40% Drop in Uncontrolled Diabetes Rates Following National AI Screening Program
The UAE's Ministry of Health reported a significant reduction in uncontrolled type 2 diabetes following the rollout of its AI-powered population-level screening program.
UAE Ministry of Health · Feb 20, 2025
FAQ
Resources
